PRESS RELEASE published on 05/05/2023 at 16:41, 2 years 6 months ago New Star Investment Trust PLC: NAV-Net Asset Value(s)
PRESS RELEASE published on 04/11/2023 at 16:55, 2 years 7 months ago New Star Investment Trust PLC: NAV-Net Asset Value(s)
PRESS RELEASE published on 03/21/2023 at 12:29, 2 years 8 months ago New Star Investment Trust PLC: Interim ANNOUNCEMENT for the Six Months to 31 12 2022
PRESS RELEASE published on 03/10/2023 at 12:07, 2 years 8 months ago New Star Investment Trust PLC: NAV-Net Asset Value(s)
PRESS RELEASE published on 02/07/2023 at 10:47, 2 years 9 months ago New Star Investment Trust PLC: NAV-Net Asset Value(s)
PRESS RELEASE published on 02/02/2023 at 11:22, 2 years 10 months ago New Star Investment Trust PLC: Listing Rule 15.6.8
PRESS RELEASE published on 01/09/2023 at 17:01, 2 years 10 months ago New Star Investment Trust PLC: Net Asset Value(s)
Published on 12/05/2025 at 02:35, 4 hours 29 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 4 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 59 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 4 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 34 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 13 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 39 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 49 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 54 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 4 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 19 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 20 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025